In a new study, researchers investigated the prevalence of cardiovascular disease events (CVE) in people with systemic lupus ...
In a recent study, researchers explored the association between HCQ and the overall risk of CV events in people with SLE.
The PALIZADE clinical study is evaluating zetomipzomib for the treatment of lupus nephritis, its side effects, and how it affects proteins in the urine. The PALIZADE clinical trial is made up of 3 ...
People with lupus have two categories of risk factors for heart disease. The traditional risk factors that affect the general population apply to people with lupus and appear more frequently among ...
Autoimmune diseases, including systemic lupus erythematosus (SLE), are more common in women than men, and scientists are ...
A recent study found that regularly checking blood levels of hydroxychloroquine (HCQ, known commercially as Plaquenil®) may ...
La Fundación Lupus de América trabaja para mejorar la calidad de vida de todas las personas afectadas por el lupus través de programas de investigación, educación, apoyo y abogacía. Join our registry, ...
An ophthalmologist conducted a visual examination which showed central retinal artery occlusion (CRAO), the blockage of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback